Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, is involved in the development and commercialization of precision diagnostics and radiopharmaceutical agents. The company is developing multiple precision diagnostic products and platforms to help identify the sites and pathways of undetected diseases and to enable better diagnostic accuracy, clinical decision-making and patient care. For more information, visit the company’s website at www.navidea.com.